What is Galaxy Medicare IPO GMP Today?
As of today, the Galaxy Medicare IPO GMP has not started yet. This means there's no unofficial premium trading in the grey market to indicate potential listing gains. This is common for new issues, especially in the SME segment. Investors should monitor this space as the IPO progresses but should base their investment decision on the company's strong fundamentals, a detailed analysis of which is provided below.
A Look at the Business: Galaxy Medicare
Galaxy Medicare Ltd. is a manufacturer, trader, and exporter of medical devices and surgical dressings. Established in 1992 and based in Bhubaneswar, Odisha, the company has built a strong presence in the healthcare and medical consumables industry.
The company’s diverse product portfolio includes:
-
Plaster of Paris (POP) Bandages and orthopedic casting tapes.
-
Surgical Dressings: Medical gauze, sterile dressings, and cotton crepe bandages.
-
Surgical Tapes: Including hypoallergenic and zinc oxide adhesive tapes.
Galaxy Medicare operates with a diversified business model that includes manufacturing its own branded products, contract manufacturing for other companies, institutional sales to government departments, and exports. This broad approach allows the company to cater to various segments of the healthcare market.
Factual Data at a Glance:
-
Total IPO Size: A book-build issue of ₹22.31 crores. This includes a fresh issue of ₹17.86 crores and an offer for sale (OFS) of ₹4.45 crores.
-
IPO Dates: The subscription window is open from September 10, 2025, and closes on September 12, 2025.
-
Listing Timeline: Allotment is expected on September 15, 2025, with a tentative listing date of September 17, 2025, on the NSE SME platform.
-
Price Band: The IPO is priced between ₹51.00 and ₹54.00 per share.
Financial Performance: An Overview
The company has a consistent financial track record, although recent profitability has been impacted by rising expenses.
-
Revenue from Operations: Revenue has shown consistent growth, increasing by 9% from ₹36.94 crore in FY24 to ₹40.27 crore in FY25.
-
Profit After Tax (PAT): While revenue grew, PAT saw a drop of 9%, from ₹3.71 crore in FY24 to ₹3.37 crore in FY25.
-
Key Ratios: The company's Return on Net Worth (RoNW) stands at 22.38% for FY25, indicating good capital efficiency.
A portion of the fresh issue proceeds will be used to purchase new machinery for its manufacturing facility in Bhubaneswar. This is a strategic move to enhance production efficiency and support future growth, particularly in its institutional and export segments.
What are the Upcoming IPOs to Watch?
Beyond the Galaxy Medicare IPO, here are some other issues grabbing attention.
-
Shringar House of Mangalsutra IPO: A specialized jewellery company. Learn more about the Shringar House of Mangalsutra IPO.
-
Nilachal Carbo Metalicks IPO: A fixed-price issue in the metallurgical sector. Get a complete overview of the Nilachal Carbo Metalicks IPO.
-
Krupalu Metals IPO: A player in the metals space. Explore the full analysis of the Krupalu Metals IPO on Finowings.
-
Taurian MPS IPO: This offering from a niche manufacturing sector is drawing attention from specialized investors. Learn more about the Taurian MPS IPO.
-
Jay Ambe Supermarkets IPO: A retail-focused offering that allows investors a chance to invest in a growing consumer business. For a complete guide, check out the Jay Ambe Supermarkets IPO analysis on Finowings.
FAQs
1. What is the business model of Galaxy Medicare?
The company manufactures, trades, and exports a range of medical devices and surgical dressings, operating through branded sales, contract manufacturing, institutional sales, and exports.
2. How will the IPO proceeds be used?
The proceeds from the fresh issue will be used to purchase new machinery for its manufacturing facility, meet working capital needs, and for general corporate purposes.
3. What is the minimum investment required?
The minimum investment for a retail investor is ₹2,16,000, which is for a lot of 4,000 shares. The minimum investment for HNIs is ₹3,24,000 for 6,000 shares.
